John Fung to Biopsy
This is a "connection" page, showing publications John Fung has written about Biopsy.
Connection Strength
0.514
-
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation. 2017 Feb; 101(2):341-349.
Score: 0.112
-
Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation. Liver Transpl. 2008 Jan; 14(1):46-52.
Score: 0.060
-
Percutaneous ultrasound-guided pancreas allograft biopsy: a single-center experience. Transplant Proc. 2005 Dec; 37(10):4436-7.
Score: 0.052
-
Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002 Nov 15; 74(9):1290-6.
Score: 0.042
-
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant. 2001 May; 1(1):47-50.
Score: 0.038
-
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation. 2001 Jan 27; 71(2):267-71.
Score: 0.037
-
Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. Exp Clin Transplant. 2018 08; 16(4):439-445.
Score: 0.031
-
Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017 Jun; 16(3):264-270.
Score: 0.029
-
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology. 1992 Sep; 16(3):671-81.
Score: 0.021
-
Reversal of protein-losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis. Liver Transpl. 2009 Dec; 15(12):1894-6.
Score: 0.017
-
Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005 Mar; 37(2):923-6.
Score: 0.012
-
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004 May; 28(5):658-69.
Score: 0.012
-
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
Score: 0.011
-
Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci. 2000 Feb; 45(2):334-9.
Score: 0.009
-
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998 Dec 27; 66(12):1596-604.
Score: 0.008
-
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation. 1997 Sep 15; 64(5):786-8.
Score: 0.007
-
Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc. 1992 Jun; 24(3):1199-200.
Score: 0.005
-
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
Score: 0.005
-
Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc. 1990 Feb; 22(1):25-34.
Score: 0.004
-
Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts. Transplant Proc. 1987 Feb; 19(1 Pt 3):2560-3.
Score: 0.004